232 Lumacaftor/Ivacaftor is associated with a significant improvement in walk test and reduction in sweat chloride in a cohort of homozygous F508del CF patients with severe disease – a single centre experience

Saved in:
Bibliographic Details
Published in:Journal of cystic fibrosis 2017-06, Vol.16, p.S122-S122
Main Authors: Ronan, N.J, McCarthy, Y, James, K, Arooj, P, Hunt, E.B, Shortt, C, Fleming, C, McCarthy, M, Howlett, C, Hickey, C, Flanagan, E, Daly, M, Eustace, J.A, Maher, M.M, Plant, B.J
Format: Article
Language:English
Subjects:
Pulmonary/Respiratory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1569-1993
1873-5010
DOI:10.1016/S1569-1993(17)30577-5